When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Alirocumab - Wikipedia

   en.wikipedia.org/wiki/Alirocumab

   Alirocumab, sold under the brand name Praluent, is a medication used as a second-line treatment for high cholesterol for adults whose cholesterol is not controlled by diet and statin treatment. It is a human monoclonal antibody that belongs to a novel class of anti-cholesterol drugs, known as PCSK9 inhibitors , and it was the first such agent ...

3. ‘Ozempic Butt’ Complaints Rise After Users Discover ... - AOL

   www.aol.com/ozempic-butt-complaints-rise-users...

   While many official side-effects that can occur from Ozempic use were listed, such as vomiting or nausea, and even pancreatitis, among others, ‘Ozempic butt’ wasn’t officially mentioned.

4. Cialis Side Effects: What to Expect (& How to Avoid Them) - AOL

   www.aol.com/cialis-side-effects-expect-avoid...

   Cialis has several common side effects, many of which also happen with other drugs used to treat ED, like sildenafil (generic Viagra®), vardenafil , and avanafil (Stendra®).

5. Ozempic Butt Isn't The Strangest Side Effect Of The Drug ...

   www.aol.com/ozempic-butt-isnt-strangest-side...

   Less-common side effects can include excess air or gas in your stomach, burping, heartburn, indigestion, fast heartbeat, low blood sugar, low energy and fatigue, or even gallstones, Dr. Comite says.

6. Evolocumab - Wikipedia

   en.wikipedia.org/wiki/Evolocumab

   Evolocumab, [6] sold under the brand name Repatha, is a monoclonal antibody that is an immunotherapy medication for the treatment of hyperlipidemia.. Evolocumab is a fully human monoclonal antibody that inhibits proprotein convertase subtilisin/kexin type 9 (PCSK9).

7. Side effects of bicalutamide - Wikipedia

   en.wikipedia.org/wiki/Side_effects_of_bicalutamide

   These side effects may occur in as many as 90% of men treated with bicalutamide monotherapy, [29] but gynecomastia is generally reported to occur in 70 to 80% of patients. [30] In the EPC trial, at a median follow-up of 7.4 years, breast pain and gynecomastia respectively occurred in 73.6% and 68.8% of men treated with 150 mg/day bicalutamide ...